SEC Filing Summary: Genmab A/S (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Genmab A/S, a foreign private issuer, for the month of March 2026. The filing date is March 2, 2026. The document serves as a correction to a previous Company Announcement (No. 13) issued on the same date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an administrative correction and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The sole material change is the issuance of a correction to a prior company announcement.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the exhibit index referencing the corrected announcement and the signature block.
Investor Verification Checklist
- Verify the content of the corrected Company Announcement (Exhibit 99.1) to understand the nature of the error in Announcement No. 13.
- Confirm the specific details of the correction by reviewing the full text of the referenced exhibit, which is not included in this summary.
- Check subsequent filings for any updated financial data or operational updates related to the corrected announcement.